An adult-based genetic risk score for liver fat associates with liver and plasma lipid traits in children and adolescents
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
An adult-based genetic risk score for liver fat associates with liver and plasma lipid traits in children and adolescents. / Huang, Yun; Stinson, Sara E; Juel, Helene Baek; Lund, Morten A V; Holm, Louise Aas; Fonvig, Cilius E; Nielsen, Trine; Grarup, Niels; Pedersen, Oluf; Christiansen, Michael; Chabanova, Elizaveta; Thomsen, Henrik S; Krag, Aleksander; Stender, Stefan; Holm, Jens-Christian; Hansen, Torben.
In: Liver International, Vol. 43, No. 8, 2023, p. 1772-1782.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - An adult-based genetic risk score for liver fat associates with liver and plasma lipid traits in children and adolescents
AU - Huang, Yun
AU - Stinson, Sara E
AU - Juel, Helene Baek
AU - Lund, Morten A V
AU - Holm, Louise Aas
AU - Fonvig, Cilius E
AU - Nielsen, Trine
AU - Grarup, Niels
AU - Pedersen, Oluf
AU - Christiansen, Michael
AU - Chabanova, Elizaveta
AU - Thomsen, Henrik S
AU - Krag, Aleksander
AU - Stender, Stefan
AU - Holm, Jens-Christian
AU - Hansen, Torben
N1 - © 2023 The Authors. Liver International published by John Wiley & Sons Ltd.
PY - 2023
Y1 - 2023
N2 - BACKGROUND & AIMS: Genome-wide association studies have identified steatogenic variants that also showed pleiotropic effects on cardiometabolic traits in adults. We investigated the effect of eight previously reported genome-wide significant steatogenic variants, individually and combined in a weighted genetic risk score (GRS), on liver and cardiometabolic traits, and the predictive ability of the GRS for hepatic steatosis in children and adolescents.APPROACH & RESULTS: Children and adolescents with overweight (including obesity) from an obesity clinic group (n = 1768) and a population-based group (n = 1890) were included. Cardiometabolic risk outcomes and genotypes were obtained. Liver fat was quantified using 1 H-MRS in a subset of 727 participants. Variants in PNPLA3, TM6SF2, GPAM and TRIB1 were associated with higher liver fat (p < .05) and with distinct patterns of plasma lipids. The GRS was associated with higher liver fat content, plasma concentrations of alanine transaminase (ALT), aspartate aminotransferase (AST) and favourable plasma lipid levels. The GRS was associated with higher prevalence of hepatic steatosis (defined as liver fat ≥5.0%) (odds ratio per 1-SD unit: 2.17, p = 9.7E-10). A prediction model for hepatic steatosis including GRS alone yielded an area under the curve (AUC) of 0.78 (95% CI 0.76-0.81). Combining the GRS with clinical measures (waist-to-height ratio [WHtR] SDS, ALT, and HOMA-IR) increased the AUC up to 0.86 (95% CI 0.84-0.88). CONCLUSIONS: The genetic predisposition for liver fat accumulation conferred risk of hepatic steatosis in children and adolescents. The liver fat GRS has potential clinical utility for risk stratification.
AB - BACKGROUND & AIMS: Genome-wide association studies have identified steatogenic variants that also showed pleiotropic effects on cardiometabolic traits in adults. We investigated the effect of eight previously reported genome-wide significant steatogenic variants, individually and combined in a weighted genetic risk score (GRS), on liver and cardiometabolic traits, and the predictive ability of the GRS for hepatic steatosis in children and adolescents.APPROACH & RESULTS: Children and adolescents with overweight (including obesity) from an obesity clinic group (n = 1768) and a population-based group (n = 1890) were included. Cardiometabolic risk outcomes and genotypes were obtained. Liver fat was quantified using 1 H-MRS in a subset of 727 participants. Variants in PNPLA3, TM6SF2, GPAM and TRIB1 were associated with higher liver fat (p < .05) and with distinct patterns of plasma lipids. The GRS was associated with higher liver fat content, plasma concentrations of alanine transaminase (ALT), aspartate aminotransferase (AST) and favourable plasma lipid levels. The GRS was associated with higher prevalence of hepatic steatosis (defined as liver fat ≥5.0%) (odds ratio per 1-SD unit: 2.17, p = 9.7E-10). A prediction model for hepatic steatosis including GRS alone yielded an area under the curve (AUC) of 0.78 (95% CI 0.76-0.81). Combining the GRS with clinical measures (waist-to-height ratio [WHtR] SDS, ALT, and HOMA-IR) increased the AUC up to 0.86 (95% CI 0.84-0.88). CONCLUSIONS: The genetic predisposition for liver fat accumulation conferred risk of hepatic steatosis in children and adolescents. The liver fat GRS has potential clinical utility for risk stratification.
U2 - 10.1111/liv.15613
DO - 10.1111/liv.15613
M3 - Journal article
C2 - 37208954
VL - 43
SP - 1772
EP - 1782
JO - Liver International
JF - Liver International
SN - 1478-3223
IS - 8
ER -
ID: 347805062